Intensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer , according to the results of a Cancer Research UK-funded clinical trial.

The TORPEdO trial funded by Cancer Research UK and The Taylor Family Foundation, led by The Christie NHS Foundation Trust and sponsored by the Institute of Cancer Research, London, compared two forms of highly targeted radiotherapy for head and neck cancer – proton beam therapy (PBT) and intensity-modulated radiotherapy (IMRT).

Presented at the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco, California, the initial results of this multi-centre trial found that there was no need for PBT for most people with head and neck cancer. Similar levels of side-effects from t

See Full Page